The Berried Clubby Molt & Moss
Menu

All evidence comparisons

Different endpointDifferent exposureDifferent methodTaxon identity

A biological response is not automatically a care threshold

Why do chemical studies show responses without yielding one safe aquarium number?

Why it looks conflicting

Mortality, enzyme activity and transcript abundance may change at different concentrations and times, tempting readers to interpret the lowest observed response or a no-death result as a universal safety line.

Bounded reconciliation

These endpoints answer different questions. Molecular or biochemical responses can occur without measured mortality, while a short no-death observation does not establish chronic safety. Nominal exposure, water chemistry and taxon verification also affect transferability.

Still unresolved

The corpus does not establish a universal home-aquarium copper threshold, product-dose rule, antidote or chronic no-effect level for every water chemistry and line.

Decision boundary: Do not convert a short laboratory response into a medication dose or safe household concentration. Identify the actual substance and formulation, preserve uncertainty and seek product-specific professional guidance when stakes are high.

Compare the exact records

2015direct-neocaridina

Physiological Response of Neocaridina denticulate to the Toxicity of Cu2+ and Chlorpyrifos

Role in this comparison: Measures five-day mortality observations and muscle biomarkers under nominal sublethal series.

What the record supports: Under the tested semi-static protocols, nominal copper-ion and chlorpyrifos concentration series were associated with time-varying muscle protein, lipid-peroxidation and enzyme-activity measurements. No deaths were reported through five days in these sublethal treatment groups.

What the record does not support: The wild-source taxon was not independently verified as N. davidi, concentrations were nominal rather than analytically measured, animals were fasted for five days and sampling-to-beaker mapping is unclear. The paper cites 96-hour LC50 values from earlier work to select its fractions but does not provide that acute experiment, uncertainty or full analysis, so those values are not results of this five-day series. Repeated t tests and one-way ANOVAs across concentration-by-day contrasts had no reported multiplicity or repeated-time model, and the text contains concentration-label inconsistencies. Muscle biomarkers do not establish a no-effect level, chronic safety, diagnosis, antidote, aquarium dose or universal copper or pesticide threshold.

Open the underlying source

2018direct-neocaridina

Gene expression profiling and expression analysis of freshwater shrimp (Neocaridina denticulata denticulata) using expressed sequence tags and short-term exposure to copper

Role in this comparison: Measures pooled whole-body transcript responses under incompletely reported short copper exposures.

What the record supports: Under the reported short-term nominal copper protocol, all 14 selected transcripts varied in at least part of the time or concentration series, and nine were reported to increase by more than two-fold at one or more observations from 1 to 24 hours. This supports a candidate short-term pooled whole-body transcriptional response, not a validated field biomarker.

What the record does not support: The copper material, concentration used for the time series, exposure vessels, independent vessel replication, allocation, acclimation, feeding, water renewal and measured water concentrations were not reported. The prose loses the dose unit while the figure labels micrograms per litre, and the stated 28 PSU salinity conflicts with the freshwater lake description. Pooling makes the biological denominator unclear, beta-actin stability and PCR efficiencies were not reported, and repeated target-by-time and target-by-dose tests had no reported multiplicity model. Transcript changes do not establish protein abundance, toxicity, survival, molting impairment, immune competence, chronic harm, a safe concentration, diagnosis or validated biomarker panel.

Open the underlying source

Related public claim checks

Reviewed 2026-08-12. Challenge this comparison or provide a missing source.